Irisin enhances longevity by boosting SIRT1, AMPK, autophagy and telomerase
Open accessAbstract
Ageing is characterised by the accumulation of molecular and cellular damage through time, leading to a decline in physical and mental abilities. Currently, society has experienced a rapid increase in life expectancy, which has led to an increase in age-associated diseases. Therefore, it is crucial to study the process of ageing to guarantee the best conditions in the final stages of life. In recent years, interest has increased in a myokine known as irisin, which is secreted during physical exercise. This polypeptide hormone is produced by various organs, mainly muscle, and once it is released into the blood, it performs a wide variety of functions that are involved in metabolic control and may be relevant during some of the diseases associated with ageing. The aim of this review is to highlight the recent studies of irisin, such as its mechanism of expression, blood release, distribution, tissue target and participation in various cellular metabolic reactions and the relationship with key anti-ageing pathways such as adenosine monophosphate-activated protein kinase, silent information regulator T 1, autophagy and telomerase. In conclusion, irisin is a key player during the ageing process and it could be a novel target molecule for the therapeutic approach to boost longevity pathways. However, more research will be necessary to use this promising hormone for this gain.
Verified 2026-10-06 · 1 reference not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This review summarizes evidence that irisin, an exercise-induced myokine, activates AMPK, SIRT1, autophagy and telomerase, potentially promoting longevity. It concludes that irisin is a promising anti-ageing target, but more research—especially clinical trials and reliable measurement methods—is needed.
Key findings
- Irisin is a 112-amino-acid polypeptide (~12 kDa), 100% conserved in human, mouse and rat, produced via exercise-induced PGC-1α/FNDC5 signalling; it acts as a myokine/adipokine with pleiotropic effects across muscle, adipose tissue, bone, brain, liver, pancreas, heart and vasculature.
- The review links irisin to four longevity pathways: AMPK activation and energy metabolism; SIRT1/PGC-1α antioxidant and mitochondrial protection; autophagy via AMPK–ULK1 and changes in LC3-II/p62; and telomerase/telomere length, including a reported positive correlation between plasma irisin and telomere length in healthy non-obese adults.
- Human data cited include disease-free centenarians showing the highest serum irisin levels (35.3 ± 5.5 ng/ml) compared with young healthy individuals (20.7 ± 6.3 ng/ml) and young patients with acute myocardial infarction (15.1 ± 5.4 ng/ml); a clinical trial in 90 overweight/obese type 2 diabetic men and women supplemented with vitamin D showed parallel significant increases in plasma irisin and SIRT1.
- Injected recombinant irisin has a reported half-life of about 1 h in mice, with hepatobiliary and renal systems acting together for excretion; however, no confirmed reference values for circulating irisin exist in rodents or humans.
Methods
- Narrative review; no primary experimental data. It synthesizes preclinical and clinical literature on irisin biosynthesis, secretion, distribution, target tissues and its relationship with AMPK, SIRT1, autophagy and telomerase.
- Includes tables summarizing irisin target tissues/signalling pathways and irisin inducers, plus figures depicting irisin production and its convergence on longevity pathways.
- Main analysis is qualitative synthesis of cited cell, rodent and human studies; no systematic search strategy, meta-analysis or new sample is described.
Limitations
- The paper states that there are no confirmed reference values for circulating irisin in rodents or humans; there is high variability in detection, low correlations between different ELISAs, and low correlations between ELISA and mass spectrometry, so no reliable and reproducible measurement method is yet available.
- The paper states that most studies are preclinical, few clinical trials have assessed irisin effects on longevity pathways such as AMPK, SIRT1, autophagy or telomere length, and more research on irisin pharmacokinetics and pharmacodynamics is needed.
- Evident from the text: as a narrative review, it does not systematically appraise study quality or risk of bias, and its conclusions rely on cited studies with heterogeneous designs, species and methods; no primary data are presented to independently verify the proposed mechanisms.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 108 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Disease-free centenarians showed the highest serum irisin levels (35.3 ± 5.5 ng/ml) compared with young healthy individuals (20.7 ± 6.3 ng/ml) and young patients with acute myocardial infarction (15.1 ± 5.4 ng/ml).
“They found that the group of disease-free centenarians showed the highest serum irisin levels (35.3 ± 5.5 ng/ml) compared with young healthy individuals (20.7 ± 6.3 ng/ml) and especially in comparison with young patients with acute myocardial infarction (15.1 ± 5.4 ng/ml).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 13
Not checked in the free run.
- Premisecitation
Physical exercise has a significant positive effect on blood irisin levels in young individuals, healthy older adults, and obese older adults.
“a recent meta-analysis whose objective was to determine the long-term effect of physical exercise on irisin levels in individuals of different ages and physical conditions concluded that, although there is great variability in the studies because of methodological issues and on the type of training, physical exercise had a significant positive effect on blood irisin levels in young individuals, in”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 12
Not checked in the free run.
- Premisecitation
Irisin release is exercise-dependent: increased physical activity stimulates PPAR-γ and PGC-1α in muscle cells, resulting in increased circulating irisin.
“It has been established that the release of this hormone is exercise-dependent, since the increase in physical activity stimulates, in muscle cells, the production of the peroxisome proliferator-activated receptor (PPAR-γ) and its transcriptional coactivator (PGC-1α). This results in the increase of circulating irisin (Fig. 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 4
Not checked in the free run.
- Premisecitation
Treatment with an AMPK inhibitor prevented irisin-induced AMPK phosphorylation and regulation of metabolic genes.
“To confirm that the effect was because of irisin, cells were treated with an AMPK inhibitor and it was found that irisin-induced AMPK phosphorylation and regulation of metabolic genes were effectively prevented under these conditions.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 15
Not checked in the free run.
- Interpretationreasoning
Irisin exerts its effects through different pathways that summarise several favourable effects of physical exercise, including white adipocyte browning, neural proliferation, bone metabolism or glucose homeostasis.
“Therefore, irisin exerts its effects through different pathways that summarise several of the favourable effects of physical exercise, including white adipocyte browning, neural proliferation, bone metabolism or glucose homoeostasis.”
Quote in the paperNot a substantial claim
- Premisecitation
Irisin induces AMPK phosphorylation and activation in vitro.
“among them, irisin has been shown to induce AMPK phosphorylation and activation in vitro (Ref. 15).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 15
Not checked in the free run.
- Premisecitation
Irisin treatment increased AMPK phosphorylation in differentiated muscle cells.
“Again, a study linking the role of irisin in hypoglycaemic situations with AMPK function in differentiated muscle cells and confirmed that irisin treatment increased AMPK phosphorylation (Ref. 56).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 56
Not checked in the free run.
- Premisecitation
FNDC5 overexpression improved insulin resistance via the AMPK pathway.
“Other studies have shown that FNDC5 overexpression improved insulin resistance via AMPK pathway (Ref. 25).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 25
Not checked in the free run.
- Premisecitation
Irisin can induce anti-apoptotic signals in response to cerebral ischaemia mediated by AKT and ERK1/2 activation in mice.
“Studies in mice showed that irisin can induce anti-apoptotic signals in response to cerebral ischaemia mediated by AKT and ERK1/2 activation (Ref. 34)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 34
Not checked in the free run.
- Premisecitation
In a 6-OHDA animal model of PD, irisin induced by exercise (treadmill running for 16 weeks) before disease induction prevented motor and cognitive behaviour dysfunction.
“In a different animal model of PD (6-hydroxydopamine (6-OHDA)), authors demonstrated that irisin induced by exercise (treadmill running for 16 weeks), before disease induction, prevented motor and cognitive behaviour dysfunction (Ref. 46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 46
Not checked in the free run.
- Premisecitation
AMPK promotes healthy ageing by integrating multiple signalling and transcription pathways known to favour longevity, including mitochondrial biogenesis, autophagy, beta-oxidation and glucose uptake.
“The attractiveness of AMPK as a promoter of healthy ageing is based on its ability to integrate multiple signalling and transcription pathways that are known to favour longevity (mitochondrial biogenesis, autophagy, beta-oxidation or glucose uptake, among others) (Ref. 55).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 55
Not checked in the free run.
- Premisecitation
Irisin circulating levels in cerebrospinal fluid are age-related increased in healthy humans even in elderly.
“despite that irisin circulating levels in cerebrospinal fluid (CSF) are age-related increased in healthy humans even in elderly (Refs 32, 33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Refs 32, 33
Not checked in the free run.
- Premisecitation
Irisin levels are reduced in CSF of AD mice and patients.
“In addition, irisin levels were found reduced in CSF of AD mice and patients.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 36
Not checked in the free run.
- Premisecitation
In mice with genetic deletion of irisin, cognitive function is impaired during exercise, ageing and AD.
“In mice with genetic deletion of irisin cognitive function is impaired during exercise, ageing and AD (Ref. 42).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 42
Not checked in the free run.
- Interpretationreasoning
Irisin could be the linkage molecule between brain and skeletal muscle that exerts its beneficial effects through BDNF expression.
“All these facts support the idea that irisin could be the linkage molecule between brain and skeletal muscle that exert its beneficial effects through BDNF expression.”
Quote in the paperSubstantial claim- Rests on an assumption: The effects of irisin observed in animal and cell models are relevant to human ageing and longevity.
- Interpretationcitation
Circulating irisin levels could be significantly associated with prosperous ageing free of associated diseases.
“These data seem to indicate that circulating irisin levels could be significantly associated with prosperous ageing free of associated diseases.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 13
Not checked in the free run.
- Rests on an assumption: The association between high circulating irisin levels and disease-free longevity reflects a causal role of irisin in longevity.
- Premisecitation
Irisin mediates PGC-1α-induced browning of WAT through upregulation of UCP-1 expression in adipocytes, partly via increased PPAR-α expression.
“Boström et al. (Ref. 4) showed that irisin was involved in mediating the PGC-1α-induced browning of WAT through upregulation of UCP-1 expression in adipocytes, partly via increased PPAR-α expression (Fig. 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 4
Not checked in the free run.
- Premisecitation
Evidence suggests that sole injection of irisin in mice could substitute exercise itself without loss of its potential benefit.
“Evidence suggests that the sole injection of irisin in mice could even substitute the exercise itself without the loss of its potential benefit (Ref. 50).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 50
Not checked in the free run.
- Premisecitation
Activation of the cAMP-PKA-CREB pathway mediated by irisin enhances BDNF, rescuing synaptic plasticity in a model of AD.
“The activation of this pathway mediated by irisin enhances BDNF, rescuing the synaptic plasticity in a model of AD (Ref. 36).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 36
Not checked in the free run.
- Premisecitation
Irisin augments insulin-induced PI3K/Akt signalling activity, leading to increased glucose inflow to muscle cells by promoting GLUT4 translocation to the membrane.
“Thus, irisin augments insulin-induced phosphatidylinositol 3-kinase (PI3K)/Akt signalling activity which leads to the increase of glucose inflow to the muscle cell by promoting glucose transporter type 4 translocation to the membrane (Ref. 24).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 24
Not checked in the free run.
- Interpretationreasoning
The decrease in ATP that determines a low-energy level may be the trigger for irisin-mediated AMPK phosphorylation and its consequent effects on cellular metabolism.
“In this way, the decrease in the amount of ATP that determines a low-energy level may be the trigger for irisin-mediated AMPK phosphorylation and its consequent effects on cellular metabolism.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 15
Not checked in the free run.
- Premisecitation
AMPK is a key activator of autophagy through a mechanism involving mTOR inhibition and activation by phosphorylation of FOXO-3 and ULK-1.
“AMPK has been recognised as a key activator of autophagy through a mechanism that involves mTOR inhibition (under starvation conditions, or when the AMP/ATP ratio is raised) and activation by phosphorylation of FOXO-3 and the Ser/Thr protein-ULK-1 kinase, proteins involved in the development of the autophagic process (Ref. 85).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 85
Not checked in the free run.
- Premisereasoning
An increase in PGC1-α determines increased expression of FNDC5 and consequently the release of irisin.
“Therefore, the increase in PGC1-α determines the increased expression of FNDC5 and consequently the release of irisin.”
Quote in the paperNot a substantial claim - Premisecitation
The activation of autophagy by irisin in hypertrophic heart models was mediated by AMPK activating phosphorylation on ULK-1.
“The activation of autophagy was mediated by irisin by activating AMPK, which carried out an activating phosphorylation on ULK-1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 89
Not checked in the free run.
- Premisecitation
In INS-1E cells, irisin reversed intracellular accumulation of non-esterified fatty acids and triglycerides induced by glucolipotoxicity through activation of AMPK signalling.
“Thus, in rat insulinoma cell line (INS-1E) models for insulin secretion regulation and pancreatic islet beta-cell function studies, irisin reversed the intracellular accumulation of non-esterified fatty acids (NEFAs) and triglycerides induced by glucolipotoxicity through the activation of AMPK signalling.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 60
Not checked in the free run.
- Premisecitation
In C2C12 myoblast cells, irisin induced reversion of insulin resistance through induction of autophagy.
“Other studies in C2C12 myoblast cells showed that irisin induced reversion of insulin resistance through induction of autophagy.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 92
Not checked in the free run.
- Premisecitation
Irisin suppressed overnutrition-induced inflammation in INS-1E cells.
“Irisin also suppressed overnutrition-induced inflammation in INS-1E cells, providing scientific basis that irisin has potential benefit in pancreatic β-cells (Ref. 60).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 60
Not checked in the free run.
- Premisecitation
The AMPK pathway is one of the promoters of healthy ageing through the regulation of various aspects of metabolism.
“In short, the AMPK pathway is one of the promoters of healthy ageing through the regulation of various aspects of metabolism.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 55
Not checked in the free run.
- Premisecitation
Rats treated with resveratrol or grape juice increased the expression of genes FNDC5/UCP-2 in muscle but not in adipose tissue.
“However, other experiments found that rats treated with resveratrol or grape juice increased the expression of genes FNDC5/UCP-2 in muscle but not in adipose tissue (Ref. 80) (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 80
Not checked in the free run.
- Premisecitation
In healthy non-obese individuals, telomere length has no correlation with anthropometric or inflammatory parameters.
“the results showed no correlation of TL with anthropometric or inflammatory parameters; however, TL has a significant negative correlation with age and a significant positive correlation with plasma irisin levels; the greater the amount of irisin present in the individual, the greater the TL.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 3
Not checked in the free run.
- Interpretationreasoning
Irisin has potential to link the molecular mechanism of exercise with its beneficial effect on diseases and ageing.
“Although it is necessary to continue investigating the role of irisin in autophagy, it seems that this myokine has a potential to link the molecular mechanism of exercise with its beneficial effect on diseases and ageing (Fig. 2).”
Quote in the paperSubstantial claim - Premisecitation
In obese mice, irisin injection improved endothelial function.
“A similar effect was obtained in another similar study with obese mice that showed endothelial function improvement after injection with irisin (Ref. 64).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 64
Not checked in the free run.
- Premisecitation
Irisin inhibits the growth of pancreatic cancer cells in a dose-dependent manner by inhibiting the mTOR pathway and activating AMPK signalling.
“Moreover, irisin has also been seen to inhibit the growth of pancreatic cancer cells in a dose-dependent manner by inhibiting the mammalian target of rapamycin (mTOR) pathway and activating the AMPK signalling (Ref. 61).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 61
Not checked in the free run.
- Interpretationreasoning
The activity and regulation of AMPK are integrated into a complex feedback network in which molecules such as PGC1-α, SIRT1 and irisin participate.
“In this context, the activity and regulation of AMPK are integrated into a complex feedback network in which molecules such as PGC1-α, SIRT1 and irisin participate.”
Quote in the paperNot a substantial claim - Premisecitation
In hypoxia/reoxygenated injury-induced endoplasmic reticulum stress, irisin has a protective effect on cardiomyocytes in an AMPK-dependent manner.
“Also, in hypoxia/reoxygenated injury-induced endoplasmic reticulum stress irisin has a protective effect on cardiomyocytes in an AMPK-dependent manner (Ref. 65).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 65
Not checked in the free run.
- Premisenone given
Irisin can activate the SIRT1 pathway in many tissues.
“However, irisin can also activate the SIRT1 pathway in many tissues.”
Quote in the paperNot a substantial claim - Premisecitation
Muscle biopsy of male cyclists after 3 days of exhaustive training showed both acute and chronic elevations in PGC-1α and SIRT1 mRNA expression.
“Also, muscle biopsy of male cyclist after 3 days of exhaustive training showed both acute and chronic elevations in PGC-1α and SIRT1 mRNA expression (Ref. 71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 71
Not checked in the free run.
- Premisecitation
SIRT1 and its orthologues participate in regulation of autophagy as activators by deacetylating atg genes and transcription factors p53, NFK-β, FOXO-1, -3, -4 and PGC1-α.
“For its part, SIRT1 and its orthologues also participate in the regulation of autophagy as activators of the process, by the deacetylation of certain genes belonging to the atg family (an important group of proteins involved in autophagy) and other transcription factors (p53, NFK-β, FOXO-1, -3, -4 and PGC1-α) (Ref. 86).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 86
Not checked in the free run.
- Premisecitation
In aged rats, SIRT1 activity increased in heart and adipose tissue after a 6-week treadmill training programme.
“Thus, in aged rats, SIRT1 activity increased in heart and adipose tissue after a 6 weeks treadmill training programme (Ref. 70).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 70
Not checked in the free run.
- Premisecitation
In rats performing swimming exercises, restoration in survival pathways pAMPK/SIRT1/PG1-α in the hippocampus occurred in an induced ageing-dependent manner after 8 weeks of training.
“Interestingly, although irisin levels were not measured, experiments with rats performing swimming exercises showed restoration in the survival pathways pAMPK/SIRT1/PG1-α in the hippocampus in an induced ageing-dependent manner after 8 weeks of training demonstrating again the relations between exercise and the enhancement of the survival pathways (Ref. 66).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 66
Not checked in the free run.
- Premisecitation
In healthy non-obese individuals, telomere length has a significant negative correlation with age.
“the results showed no correlation of TL with anthropometric or inflammatory parameters; however, TL has a significant negative correlation with age and a significant positive correlation with plasma irisin levels; the greater the amount of irisin present in the individual, the greater the TL.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 3
Not checked in the free run.
- Premisecitation
A clinical trial comparing circulating irisin after acute circuit training in overweight young adults and older adults showed a similar irisin response in both groups.
“In this regard, one of them compared circulating irisin after an acute episode of circuit training in overweight young adults and older adults and both showed a similar irisin response (Ref. 100).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 100
Not checked in the free run.
- Premisecitation
Clinical trials carried out so far have been designed to evaluate the effect of physical exercise on irisin levels and its benefit in unhealthy situations, many in age-related diseases such as type 2 diabetes, overweight/obesity, metabolic syndrome or cardiometabolic disease.
“However, clinical trials carried out so far have been designed to evaluate the effect of physical exercise on irisin levels and its benefit in unhealthy situations, many of them in age-related diseases such as type 2 diabetes, overweight/obesity, metabolic syndrome or cardiometabolic disease (Refs 95, 96, 97).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Refs 95, 96, 97
Not checked in the free run.
- Premisereasoning
There are few clinical trials studying irisin on longevity.
“But there are few clinical trials studying irisin on longevity.”
Quote in the paperSubstantial claim - Premisereasoning
There are no clinical trials to assess the effect of irisin on the longevity pathways that are the subject of this review, such as AMPK, SIRT1, autophagy or telomere length.
“However, there are no clinical trials to assess the effect of irisin on the longevity pathways that are the subject of this review, such as AMPK, SIRT1, autophagy or TL.”
Quote in the paperSubstantial claim - Premisecitation
In healthy non-obese individuals, plasma irisin levels have a significant positive correlation with telomere length in peripheral blood mononuclear cells; greater irisin, greater telomere length.
“the results showed no correlation of TL with anthropometric or inflammatory parameters; however, TL has a significant negative correlation with age and a significant positive correlation with plasma irisin levels; the greater the amount of irisin present in the individual, the greater the TL.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 3
Not checked in the free run.
- Interpretationcitation
No reliable and reproducible method is yet available for the measurement of irisin.
“On the other hand, the main limitation that currently exists in irisin studies is that there are low correlations between the levels of irisin measured with different enzyme-linked immunosorbent assays (ELISAs) and even rather low correlations between the values determined by ELISA and mass spectrometry (Refs 11, 101, 102), so it seems that no reliable and reproducible method is yet available for”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Refs 11, 101, 102
Not checked in the free run.
- Premisenone given
Most studies on irisin and longevity pathways have been done in preclinical models.
“Most of these studies have been done in preclinical models.”
Quote in the paperSubstantial claim - Premisecitation
Inhibition of telomerase activity by BIBP1532 abolished the protective role of irisin in hepatocytes during hypoxia and reoxygenation.
“Inhibition of telomerase activity by inhibitor BIBP1532 abolished the protective role of irisin in hepatocytes during hypoxia and reoxygenation (Ref. 93).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 93
Not checked in the free run.
- Interpretationcitation
High irisin levels may be related to healthy longevity in humans.
“Likewise, a clinical trial with healthy centenarians, healthy youth and myocardial infarction patients found higher serum irisin levels in disease-free centenarians (Ref. 13), suggesting that high irisin levels may be related to healthy longevity in humans.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 13
Not checked in the free run.
- Interpretationcitation
Irisin appears to exert part of its potentially anti-ageing effects through telomerase activity.
“Although more studies are needed regarding the possible effects of irisin on telomerase activity, it appears that irisin exerts part of its potentially anti-ageing effects through this mechanism (Fig. 2).”
Quote in the paperSubstantial claim - Premisecitation
In a model of hepatic ischaemia-reperfusion, irisin improved mitochondrial function via increasing telomerase activity in aged rat hepatocytes.
“Finally, in a model of hepatic IR irisin improved mitochondrial function via increasing telomerase activity in rat aged hepatocytes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 93
Not checked in the free run.
- Premisecitation
A clinical trial with healthy centenarians, healthy youth and myocardial infarction patients found higher serum irisin levels in disease-free centenarians.
“Likewise, a clinical trial with healthy centenarians, healthy youth and myocardial infarction patients found higher serum irisin levels in disease-free centenarians (Ref. 13), suggesting that high irisin levels may be related to healthy longevity in humans.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 13
Not checked in the free run.
- Classified as probably not a substantial claim. 29
- May combine two claims. 62
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn some tissues, such as bone and fat, irisin acts via αV/β5 integrin receptors.
“In some tissues, such as bone and fat, irisin acts via αV/β5 integrin receptors (Ref. 6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 6
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIrisin is secreted in white adipose tissue (WAT), mainly in subcutaneous adipose tissue (SAT) adipocytes and at a lower extent in visceral adipose tissue adipocytes, with expression increasing during physical activity.
“Irisin is also secreted in white adipose tissue (WAT), so it may also behave as an ‘adipokine’. Regarding this tissue, it has been observed that in rodents irisin is secreted mainly in subcutaneous adipose tissue (SAT) adipocytes and, at a lower extent, in visceral adipose tissue adipocytes, with expression increasing when performing physical activity (Ref. 10).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 10
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIrisin is a myokine, expressed, produced and released by muscle fibres, exerting effects on other organs.
“Irisin is considered as a ‘myokine’, term that refers to cytokines or other peptides that are expressed, produced and released by muscle fibres exerting their effects on other organs of the body (Ref. 7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 7
Not checked in the free run.
May combine two claims.
InterpretationcitationThe αV integrin complex is probably the main irisin receptor, but other irisin receptors within or outside the integrin family are not excluded.
“Therefore, these data suggest that the αV integrin complex is probably the main irisin receptor; however, it is important to note that this does not exclude the possibility of other irisin receptors within or outside the integrin family.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 5
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIrisin is a polypeptide hormone consisting of 112 amino acids with an approximate molecular weight of 12 kDa, 100% conserved in human, mouse and rat, discovered by Boström et al. in 2012.
“Irisin is a polypeptide hormone consisting of 112 amino acids with an approximate molecular weight of 12 000 Daltons (Da; 12 kDa) 100% conserved in human, mouse and rat, discovered by Boström et al. in 2012 (Ref. 4)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 4
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIrisin is present in several human tissues including testicles, pancreas, spleen, brain and stomach, and also in salivary glands, skin, liver, kidney and heart muscle; cardiac muscle produces more irisin than skeletal muscle.
“This analysis also revealed the presence of irisin in several human tissues such as testicles, pancreas, spleen, brain and stomach (Ref. 8). Also, it was previously shown that irisin is expressed in salivary glands, skin, liver, kidney and heart muscle, and, interestingly, the authors conclude that cardiac muscle produces more irisin than skeletal muscle (Ref. 9).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ref. 8
Not checked in the free run.
- cites Ref. 9
Not checked in the free run.
May combine two claims.
PremisecitationIrisin-supplemented media from astrocytes decreased β-amyloid toxicity and decreased levels of proinflammatory cytokines (IL-6, IL-1β and COX-2).
“In vitro studies showed that irisin-supplemented media from astrocytes decreased β-amyloid toxicity also decreased the levels of proinflammatory cytokines (IL-6, IL-1β and cyclooxygenase-2 (COX-2)) (Ref. 37).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 37
Not checked in the free run.
May combine two claims.
PremisecitationSerum irisin levels were upregulated in ALS patients, while in animal models with mutant SOD1, levels of irisin and myostatin were downregulated.
“Some authors showed that serum irisin levels were upregulated in ALS patients (Ref. 48), meanwhile in animal models with mutant SOD1, levels of irisin and myostatin have found downregulated (Ref. 49).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ref. 48
Not checked in the free run.
- cites Ref. 49
Not checked in the free run.
May combine two claims.
PremisecitationDecreasing the levels of irisin in mice brain impairs cognitive behaviour, which is restored by increasing the peripheral expression of irisin.
“These authors showed how decreasing the levels of irisin in mice brain impairs cognitive behaviour that were restored by increasing the peripheral expression of irisin (Ref. 36).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 36
Not checked in the free run.
May combine two claims.
PremisecitationNo differences were found between genotypic/allelic frequencies of two FNDC5 SNPs in centenarians versus controls, nor a significant association between the two SNPs and successful disease-free longevity.
“However, no differences were found between the genotypic/allelic frequencies of the two SNPs in centenarians versus controls in either population, nor a significant association between the two SNPs and successful disease-free longevity (Ref. 14).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 14
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAmpelopsin attenuates skeletal muscle atrophy through activating AMPK/SIRT1/PGC-1α signalling cascade in rats.
“Similar effects have been found in rats treated with the flavonoid ampelopsin which attenuates the atrophy of skeletal muscle through activating AMPK/SIRT1/PGC-1α signalling cascade (Ref. 59).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 59
Not checked in the free run.
May combine two claims.
PremisecitationIn an MPTP animal model of PD, rats treated with irisin and bone marrow stromal cells prevented dopaminergic neuron loss, and irisin facilitated the stem cells with regenerative ability inducing migration of BMSCs in the damaged brain area.
“In an MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), animal model of PD, authors showed that rats treated with irisin and bone marrow stromal cells (BMSCs) prevented the dopaminergic neurons loss and irisin facilitated the stem cells with regenerative ability inducing the migration of BMSCs in the damaged brain area (Ref. 45).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 45
Not checked in the free run.
May combine two claims.
PremisecitationIn human skeletal muscle cells treated with irisin, intracellular ATP significantly decreased after 1 h, coinciding with an increase in AMPK phosphorylation.
“The researchers measured intracellular ATP in human skeletal muscle cells treated with irisin and found a significant decrease in the levels of this molecule after 1 h, this decline coincided with the increase in AMPK phosphorylation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 15
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationInjected recombinant irisin has a short half-life (1 h) in mice.
“In relation to the pharmacokinetics of irisin, a short half-life (1 h) of injected recombinant irisin in mice has been reported (Ref. 6)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 6
Not checked in the free run.
May combine two claims.
PremisecitationSkeletal muscle AMPK is necessary to maintain basal FNDC5 expression; AMPK gene knockout mice showed a drastic decrease in FNDC5 expression compared with wild-type mice.
“Another research group concluded that skeletal muscle AMPK is necessary to maintain basal FNDC5 expression, by comparing AMPK gene knockout mice with wild-type mice and observing a drastic decrease in FNDC5 expression in the first group of mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 57
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAMPK is activated when energy levels are low, influencing physiological processes to increase energy production and coordinate a decrease in ATP expenditure.
“AMPK is a highly conserved enzyme in the eukaryotic kingdom that is activated when energy levels are low, influencing a wide range of physiological processes with the purpose to increase energy production and coordinate a decrease in the expenditure of adenosine triphosphate (ATP).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 55
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationExercise improves memory, attention and neuronal plasticity even in elderly patients, being a non-pharmacological approach to prevent brain ageing vulnerable to AD, PD and stroke.
“It has been reported that exercise is involved in many physiological processes at the central nervous system that may improve memory, attention and promoting neuronal plasticity even in elderly patients, being a non-pharmacological approach to prevent the brain ageing vulnerable to AD, PD and stroke (Ref. 29).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 29
Not checked in the free run.
May combine two claims.
PremisecitationFNDC5/irisin acts through MAPK signalling pathways in neural differentiation, endothelial cell proliferation, and osteoblast proliferation and differentiation, preventing bone loss by p38 and ERK activation.
“Recent studies have shown that FNDC5/irisin acts through MAPK signalling pathways in numerous cellular processes, such as neural differentiation, endothelial cell proliferation as well as osteoblast proliferation and differentiation (Refs 25, 27) preventing bone loss by p38 and ERK activation (Ref. 28) (Fig. 2).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Refs 25, 27
Not checked in the free run.
- cites Ref. 28
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIrisin released in the blood stream by muscle can reach the brain inducing BDNF expression.
“Some authors suggest that irisin released in the blood stream by the muscle can reach the brain inducing BDNF expression (Ref. 31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 31
Not checked in the free run.
May combine two claims.
PremisecitationThe AMPK pathway is involved in PGC-1α/FNDC5 and irisin expression, as icariin enhances dose-dependent phosphorylation of AMPK and increases mRNA levels of irisin/FNDC5 in C2C12 myocytes and decreases body weight gain in mice.
“Moreover, a study demonstrated that AMPK pathway is involved in the PGC-1α/FNDC5 and irisin expression using a flavonoid, icariin, which enhances dose-dependent phosphorylation of AMPK protein and increased mRNA levels of irisin/FNDC5 in C2C12 myocytes and decreased body weight gain in mice (Ref. 58).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 58
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationAMPK, sirtuin pathways, autophagy and telomere length are well-studied pathways that regulate ageing, and their modulation influences the rate of ageing.
“Among others these include four well-studied pathways that are known to regulate ageing, and whose modulation has been shown to influence the rate of ageing, these are AMPK, and sirtuin pathways, autophagy and telomere length (TL) (Refs 51, 52, 53, 54).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Refs 51, 52, 53, 54
Not checked in the free run.
May combine two claims.
PremisecitationIrisin activates the cAMP-PKA-CREB pathway, which participates in neural differentiation and neuroprotection.
“and activate cAMP–protein kinase A (PKA)–cAMP response element-binding (CREB) pathway, which has been shown to participate in neural differentiation and neuroprotection (Ref. 35).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 35
Not checked in the free run.
May combine two claims.
PremisecitationIrisin prevented the loss of dopamine neurons and striatal dopamine levels in an α-synuclein preformed fibrils-induced model of PD, and irisin promotes endolysosomal degradation of pathological α-syn.
“Irisin also prevented the loss of dopamine neurons and striatal dopamine levels in an α-synuclein preformed fibrils (α-syn PFF)-induced model of PD. The authors suggested that irisin promotes the endolysosomal degradation of pathological α-syn (Ref. 47).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 47
Not checked in the free run.
May combine two claims.
PremisecitationIn wild-type mice, AMPK phosphorylation is increased immediately when muscle contraction occurs, an effect abolished in knockout mice.
“Likewise, in wild-type mice, AMPK phosphorylation is increased immediately when muscle contraction occurs, an effect that was abolished in knockout mice (Ref. 57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 57
Not checked in the free run.
May combine two claims.
PremisecitationAt the systemic level, irisin maintains glucose and lipid homeostasis, which is crucial in treatment for type 2 diabetes mellitus, obesity or other metabolic diseases.
“At the systemic level, irisin maintains glucose and lipids homoeostasis which is crucial in treatment for type 2 diabetes mellitus (T2DM), obesity or other metabolic diseases (Ref. 26).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 26
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIrisin can bind a specific domain between β- and α-secretase cleavage sites of amyloid precursor protein, reducing the formation of both Aβ40 and Aβ42 peptides.
“Some authors suggest that irisin can bind a specific domain between β- and α-secretase cleavage sites of amyloid precursor protein (APP) reducing the amyloid beta-peptide (Aβ) formation of both Aβ40 and Aβ42 peptides (Ref. 38).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 38
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBasal irisin is higher in young adults than in older adults; circulating irisin increases immediately after high-intensity interval exercise but not in chronic exercise; exercise-induced irisin secretion is independent of age or fitness level.
“Another study revealed that basal irisin was higher in young adults than in older adults and that circulating irisin increased immediately after high-intensity interval exercise, but not in chronic exercise, and this exercise-induced irisin secretion was independent of age or fitness level (Ref. 15).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 15
Not checked in the free run.
May combine two claims.
InterpretationcitationIrisin functions as a muscle-derived molecule that communicates directly with adipose tissue, acting as a thermogenic protein by increasing UCP-1 levels and promoting WAT browning.
“Therefore, irisin functions as a muscle-derived molecule that communicates directly with adipose tissue acting as a thermogenic protein by increasing UCP-1 levels and promoting WAT browning.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 4
Not checked in the free run.
May combine two claims.
PremisecitationThe hepatobiliary and renal systems act together to excrete irisin; after intravenous injection of 125I-irisin in mice, irisin levels were observed in gallbladder, liver and kidneys at 15 min and decreased between 30 and 120 min.
“The administration of irisin in vivo in rodents revealed that the hepatobiliary and renal systems act together to guarantee the correct excretion of the hormone. In this experiment, 125I-irisin was tracked in mice after intravenous injection using single-photon emission computed tomography and, 15 min after the injection, irisin levels were observed in the gallbladder, liver and kidneys, decre”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 16
Not checked in the free run.
May combine two claims.
PremisecitationIrisin allows crosstalk between muscle and other organs, including adipose tissue, bone, brain, liver, pancreas, vascular bed, heart and brain, as well as communication within the muscle itself.
“Irisin, as a hormone, allows a crosstalk between the muscle and other organs, including adipose tissue, bone, brain, liver, pancreas, vascular bed, heart and brain, as well as communication within the muscle itself (Ref. 18).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 18
Not checked in the free run.
May combine two claims.
PremisecitationSIRT1 deacetylates PGC1-α, activating it, which leads to regulation of mitochondrial gene expression and an increase in PGC1-α activity that, in muscle, results in an increase in circulating irisin.
“SIRT1 is of great interest in this study since one of its non-histone targets is PGC1-α, which undergoes reversible acetylation/deacetylation control; when deacetylated by SIRT1, PGC1-α is activated, which leads to the regulation of subsequent pathways involved in the control of mitochondrial gene expression and the increase in activity of PGC1-α that, in muscle, results in an increase in circul”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 68
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenSIRT1 is one of the gatekeepers that control the activity of PGC1-α, and together they determine an essential link in the regulatory network of metabolic homoeostasis.
“In conclusion, the metabolic sensor SIRT1 is one of the gatekeepers that control the activity of PGC1-α, and together they determine an essential link in the regulatory network of metabolic homoeostasis.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMetformin can promote up-regulating irisin expression in mice muscle and in INS-1E cells in a high-glucose environment through the AMPK/SIRT1/PGC-1α signal pathway, improving its function and survival.
“Thus, metformin, a widely used drug of T2DM that improves insulin sensitivity and inhibits hepatic gluconeogenesis (Ref. 75), can promote up-regulating irisin expression in mice muscle (Ref. 76) and in INS-1E cells in high-glucose environment through AMPK/SIRT1/PGC-1α signal pathway, improving its function and survival (Ref. 77).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ref. 76
Not checked in the free run.
- cites Ref. 77
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe rate of telomere shortening can increase or decrease under influence of lifestyle, so correct diet and physical exercise can reduce the rate of shortening or at least prevent excessive telomere wear.
“The rate of telomere shortening can increase or decrease under the influence of lifestyle, so that a correct diet and physical exercise can reduce the rate of shortening or at least prevent excessive telomere wear (Ref. 94).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 94
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSIRT or sirtuins are a family of NAD+ dependent proteins, initially identified as class III histone deacetylases.
“SIRT or sirtuins are a family of NAD+ dependent proteins, which were initially identified as class III histone deacetylases (Ref. 67).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 67
Not checked in the free run.
May combine two claims.
PremisecitationIn spontaneously hypertensive rats, irisin injection reduced blood pressure through the AMPK-Akt-eNOS-NO signalling pathway, increasing the release of NO.
“At the vascular level, in spontaneously hypertensive rats, it was shown that irisin injection reduced blood pressure through the AMPKAkt–endothelial NO synthase (eNOS)–nitric oxide (NO) signalling pathway, increasing the release of NO (Ref. 63).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 63
Not checked in the free run.
May combine two claims.
PremisecitationIn an animal model for acute lung injury, irisin pretreatment significantly augmented the ratio of p-AMPK/AMPK protein and up-regulated the expression of SIRT1 protein in lung tissue, improving alveolar epithelial barrier dysfunction.
“In this regard, in experiments with an animal model for acute lung injury irisin pretreatment not only significantly augmented the ratio of p-AMPK/AMPK protein, but also up-regulated the expression of SIRT1 protein in lung tissue improving the alveolar epithelial barrier dysfunction (Ref. 72).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 72
Not checked in the free run.
May combine two claims.
PremisecitationIn soleus muscle tissue of diabetic rats trained by running on a treadmill for 12 weeks, there was a significant increase in irisin and sirtuin-1 mRNA expression, which can be a compensatory mechanism for reducing oxidative stress and improving symptoms in diabetics.
“Moreover, irisin and sirtuin-1 mRNA were investigated in the soleus muscle tissue of diabetic rats that were trained by running on a treadmill for 12 weeks. The researchers found a significant increase in the expression of these genes, which can be a compensatory mechanism for reducing oxidative stress and improving the symptoms in diabetics (Ref. 73).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 73
Not checked in the free run.
May combine two claims.
Premisenone givenmTOR is the primary inhibitor of autophagy in both animal models and humans; IGF-1 signals through IGF1-R to activate mTOR and inhibit autophagy.
“In contrast, mTOR is the primary inhibitor of autophagy in both animal models and humans; IGF-1 signals through its IGF1-R receptor that activates mTOR to inhibit autophagy.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationExogenous irisin increased LC3-II and decreased p62 in hypertrophic heart models, indicating irisin promotes autophagy and autophagic flow protecting against pressure overload-induced cardiac hypertrophy.
“In this experiment, markers LC3-II (number of autophagosomes) and p62 (protein that is degraded in the process and serves to determine autophagic flow) were measured; the supply of exogenous irisin increased the levels of LC3-II and decreased those of p62, that is, irisin promotes autophagy and autophagic flow protecting against pressure overload-induced cardiac hypertrophy (Ref. 89).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 89
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAutophagy is a highly conserved catabolic process in eukaryotes activated under nutrient scarcity, resulting in renewal of cytoplasmic material and mobilisation of macromolecules to generate energetic compounds.
“Autophagy is a highly conserved catabolic process in eukaryotes that is activated under conditions of nutrient scarcity, and results in the renewal of cytoplasmic material as well as the mobilisation of macromolecules to generate highly energetic compounds that cover cellular demands under conditions of decreased internal or external resources (Ref. 83).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 83
Not checked in the free run.
May combine two claims.
PremisecitationIn cardiomyocytes with Ang-II-induced hypertrophic damage, Ang-II increased LC3-II and p62, indicating increased autophagy but flow blockage.
“Ang-II increased the levels of LC3-II and p62, which indicates an increase in the level of autophagy but a flow blockage, that is, although there is an increase in autophagy, the process is failing by not being resolved appropriately.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 91
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAll neurodegenerative diseases share certain pathogenic mechanisms, including age-associated autophagic flux imbalance that causes an inability to remove neurotoxic oligomers or misfolded proteins.
“All neurodegenerative diseases share certain pathogenic mechanisms, including age-associated autophagic flux imbalance that causes an inability to remove neurotoxic oligomers or misfolded proteins (Ref. 84).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 84
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSIRT1 is expressed mainly in the nucleus, although under certain specific conditions it can act on cytosolic proteins.
“Within this family, the most studied enzyme is SIRT1, a protein that is expressed mainly in the nucleus, although under certain specific conditions it can act on cytosolic proteins (Ref. 69).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 69
Not checked in the free run.
May combine two claims.
PremisecitationA clinical trial with 90 men and women with type 2 diabetes and overweight/obesity who were supplemented with vitamin D showed a parallel significant increase in plasma levels of irisin and SIRT1, supporting the link between these two molecules, considering that SIRT1 stimulates PGC-α which in turn enhances irisin production.
“In the same sense, a clinical trial with 90 men and women with type 2 diabetes and overweight/obesity who were supplemented with vitamin D showed that there was a parallel significant increase in the plasma levels of irisin and SIRT1 supporting the link between these two molecules, considering that SIRT1 stimulates PGC-α which in turn enhances irisin production (Table 2).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningSIRT1/PGC1-α and FNDC5/irisin can potentiate each other, and this relationship could explain many of the protective effects related to physical activity.
“In fact, it seems that SIRT1/PGC1-α and FNDC5/irisin can potentiate each other and the relationship between them could explain many of the protective effects related to physical activity.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIrisin is a key player during the ageing process and could be a novel target molecule for the therapeutic approach to boost longevity pathways.
“In conclusion, irisin is a key player during the ageing process and it could be a novel target molecule for the therapeutic approach to boost longevity pathways.”
Quote in the paperSubstantial claim- Rests on an assumption: The effects of irisin observed in animal and cell models are relevant to human ageing and longevity.
- Rests on an assumption: The association between high circulating irisin levels and disease-free longevity reflects a causal role of irisin in longevity.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSirtuins are essential regulators of the control network of energy homeostasis and participate in a wide number of cellular processes such as glucose and fat metabolism, exerting their action on numerous nuclear transcriptional factors and on specific cytoplasmic and mitochondrial proteins.
“Later, it was discovered that they were essential regulators of the control network of energy homoeostasis and participated in a wide number of cellular processes (such as glucose and fat metabolism), exerting their action on numerous nuclear transcriptional factors and on specific cytoplasmic and mitochondrial proteins.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 68
Not checked in the free run.
May combine two claims.
PremisecitationIn hypertrophic heart models, irisin deficiency caused a decrease in autophagy and aggravated autophagic failure, whereas exogenous irisin induced autophagy and improved the process.
“Recently, studies with hypertrophic heart models comparing wild-type mice with FNDC5 knockout mice showed that irisin deficiency caused a decrease in autophagy and aggravated autophagic failure, whereas exogenous supply of irisin induced autophagy and improved the development of the process.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 89
Not checked in the free run.
May combine two claims.
PremisecitationResveratrol administered orally in mice and in humans determined an increase in the expression of FNDC5 and UCP-1 in SAT and improves the glycaemic and lipid profiles; SIRT1 is the candidate molecule mediating the relationship between resveratrol administration and the increase in FNDC5 and UCP-1.
“Resveratrol administered orally in mice and in humans determined an increase in the expression of FNDC5 and UCP-1 in SAT and improves the glycaemic and lipid profiles. In this study it was shown that the candidate molecule that would mediate the relationship between the administration of resveratrol and the increase in FNDC5 and UCP-1 would be SIRT1 (Ref. 79).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 79
Not checked in the free run.
May combine two claims.
PremisecitationAutophagy promotes longevity in model organisms, and although this role is not fully established in mammals, an increase in autophagy is an effective mechanism to prevent premature ageing, improve health and promote longevity in mammals.
“Numerous studies show that autophagy promotes longevity in model organisms, and although this role is not fully established in mammals, it is known that an increase in autophagy is an effective mechanism to prevent premature ageing, improve health and promote longevity in mammals (Ref. 83).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 83
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome beneficial effects of physical activity are related to autophagy induction in many tissues including muscle, adipose tissue, liver, pancreas, heart or brain.
“Some of the beneficial effect of physical activity seen to be related to autophagy induction in many tissues including muscle, adipose tissue, liver, pancreas, heart or brain (Refs 87, 88).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Refs 87, 88
Not checked in the free run.
May combine two claims.
PremisecitationExogenous irisin supplementation reduces p62 and increases LC3-II in Ang-II-treated cardiomyocytes, promoting increased autophagy and autophagic flux.
“Exogenous irisin supplementation reduces p62 levels and increases LC3-II levels, promoting increased autophagy and autophagic flux.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 91
Not checked in the free run.
May combine two claims.
PremisecitationIn old rats with hepatic ischaemia-reperfusion, exogenous recombinant irisin increased p62 and LC3BII proteins and autophagosomes, improving inflammation, oxidative stress, apoptosis and liver injury.
“Interestingly, hepatic ischaemia–reperfusion (IR) of old rats treated with exogenous recombinant irisin showed higher level of p62 and LC3BII proteins and higher amount of autophagosomes improving inflammation, oxidative stress, apoptosis and liver injury in an old rat model of hepatic IR (Ref. 93).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 93
Not checked in the free run.
May combine two claims.
PremisecitationIn Ang-II-treated cardiomyocytes, irisin increased both autophagosomes and autophagolysosomes, translating into correct functioning and resolution of the autophagic mechanism.
“Also, when applying irisin, an increase in both autophagosomes and autophagolysosomes was observed, which translates into correct functioning and resolution of the autophagic mechanism (Ref. 91).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 91
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenRegulation of autophagy involves pro-ageing molecules mTOR and IGF-1, as well as anti-ageing molecules SIRT and AMPK.
“The regulation of autophagy involves pro-ageing molecules such as mTOR and insulin-like growth factor-1 (IGF-1), as well as anti-ageing molecules, such as SIRT and AMPK.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn hypoxia-treated cardiomyocytes in vitro and infarcted hearts in vivo, irisin enhanced autophagy, favouring elimination of damaged mitochondria and protecting them from further damage following myocardial infarction, resulting in increased ATP levels in response to hypoxia.
“In studies on hypoxia-treated cardiomyocytes in vitro and on infarcted hearts in vivo irisin was capable to enhance autophagy favouring the elimination of the damaged mitochondria and protect them from further damage following myocardial infarction, resulting in an increase in ATP levels in response to hypoxia (Ref. 90).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 90
Not checked in the free run.
May combine two claims.
PremisecitationC2C12 cells augmented the autophagic rate increasing LC3 and increased p62 degradation.
“Thus, C2C12 cells augmented the autophagic rate increasing the level of the autophagosome marker LC3, and increased p62 degradation (Ref. 92).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 92
Not checked in the free run.
May combine two claims.
InterpretationcitationThe secretion of irisin by muscle depends on AMPK signalling and, in turn, irisin has an autocrine effect, increasing the AMPK pathway and improving the metabolism and function of the muscle itself.
“All these experiments show how the secretion of irisin by the muscle depends on AMPK signalling and, in turn, irisin has an autocrine effect, increasing the AMPK pathway and thus improving the metabolism and function of the muscle itself (Fig. 3).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningWith physical exercise and the consequent increase in irisin levels, activation of AMPK and its subsequent positive effects on energy metabolism could be promoted, resulting in a favourable process.
“With the performance of physical exercise and the consequent increase in irisin levels, the activation of AMPK and its subsequent positive effects on energy metabolism could be promoted, which results in a favourable process.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningIrisin could be a likely agent for anti-ageing strategies, but more research is necessary to overcome controversies regarding its use in ageing.
“In the next few decades, researchers will face the challenge of seeking anti-ageing strategies that will enable us to find healthy and disease-free ageing and irisin could be a likely agent, but more research will be necessary to overcome some controversies raised regarding the use of this promising hormone in ageing.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMeta-analyses have reported decreased irisin values in patients with coronary heart disease.
“In fact, different meta-analyses have reported decreased irisin values in patients with diseases such as coronary heart disease (Ref. 103) or osteoporosis (Ref. 104), but the reported irisin levels were highly variable, from pg to μg/ml, which limits their validity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 103
Not checked in the free run.
May combine two claims.
InterpretationcitationIrisin is a hormone with anti-ageing properties.
“These results determine that irisin is a hormone with anti-ageing properties, although the precise mechanism by which irisin promotes telomere lengthening is unknown.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 3
Not checked in the free run.
May combine two claims.
InterpretationreasoningIrisin is a key player during the ageing process and could be a novel target molecule for therapeutic approach to boost longevity pathways.
“In conclusion, as this revision suggests, irisin is a key player during the ageing process and it could be a novel target molecule for the therapeutic approach to boost longevity pathways.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningPart of the effects of physical exercise could be mediated by irisin signalling through activation of AMPK, SIRT1, telomere elongation and autophagy, in an autocrine and endocrine manner.
“Part of these effects could be mediated by irisin signalling, through the activation of other molecules and cellular processes associated with the promotion of healthy ageing and increased life expectancy, such as AMPK, SIRT1, telomere elongation and autophagy, both in an autocrine and endocrine manner.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductcitationReported irisin levels in these meta-analyses were highly variable, from pg to μg/ml, which limits their validity.
“In fact, different meta-analyses have reported decreased irisin values in patients with diseases such as coronary heart disease (Ref. 103) or osteoporosis (Ref. 104), but the reported irisin levels were highly variable, from pg to μg/ml, which limits their validity.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ref. 103
Not checked in the free run.
- cites Ref. 104
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMeta-analyses have reported decreased irisin values in patients with osteoporosis.
“In fact, different meta-analyses have reported decreased irisin values in patients with diseases such as coronary heart disease (Ref. 103) or osteoporosis (Ref. 104), but the reported irisin levels were highly variable, from pg to μg/ml, which limits their validity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ref. 104
Not checked in the free run.
May combine two claims.
Interpretationnone givenScientific evidence shows irisin performs its role in various tissues such as the cardiovascular system, adipose tissue, liver, skeletal muscle, pancreas or brain, participating in metabolic processes responsible for maintaining cellular homoeostasis and stimulating anti-ageing signalling pathways, which would promote beneficial longevity with fewer diseases.
“Scientific evidence shows that irisin performs its role in various tissues such as the cardiovascular system, adipose tissue, liver, skeletal muscle, pancreas or brain, participating in metabolic processes responsible for maintaining cellular homoeostasis and stimulating anti-ageing signalling pathways, which would promote beneficial longevity with fewer diseases (Fig. 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenPhysical exercise can be recognised as a non-pharmacological strategy to counteract dysfunctions associated with age.
“Physical exercise can be recognised as a non-pharmacological strategy to counteract dysfunctions associated with age.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOther trials focus on supplementation with substances known for anti-ageing effect, such as metformin, resveratrol or vitamin D, on irisin secretion and the latter also on levels of SIRT1.
“Other trials focus on the study of supplementation with substances known for their anti-ageing effect, such as metformin (Ref. 98), resveratrol (Ref. 79) or vitamin D (Ref. 99), on irisin secretion and the latter also on levels of SIRT1.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Ref. 98
Not checked in the free run.
- cites Ref. 79
Not checked in the free run.
- cites Ref. 99
Not checked in the free run.
May combine two claims.
Study design and conductcitationThere are low correlations between irisin levels measured with different ELISAs and between ELISA and mass spectrometry.
“On the other hand, the main limitation that currently exists in irisin studies is that there are low correlations between the levels of irisin measured with different enzyme-linked immunosorbent assays (ELISAs) and even rather low correlations between the values determined by ELISA and mass spectrometry (Refs 11, 101, 102), so it seems that no reliable and reproducible method is yet available for”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Refs 11, 101, 102
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenNatural compounds and various drugs can modulate levels of irisin and could interact with the longevity signalling pathway.
“Another interesting aspect of irisin is the potential use in preventive/therapeutic strategies, thanks to the possibility of using natural compounds and various drugs that can modulate the levels of this myokine and that could interact with the longevity signalling pathway (Table 2).”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The effects of irisin observed in animal and cell models are relevant to human ageing and longevity.
“This would provide a major stride in elderly patients with restrained mobility capabilities.”
The paper relies on this without support.
The association between high circulating irisin levels and disease-free longevity reflects a causal role of irisin in longevity.
“These data seem to indicate that circulating irisin levels could be significantly associated with prosperous ageing free of associated diseases.”
The paper relies on this without support.
Telomere length is a valid marker of the state of ageing in humans.
“That is why telomere length (TL) is considered as a ‘molecular clock’ that determines the state of ageing of the organism.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Irisin increases telomerase activity to extend lifespan.
“Irisin has also been revealed to increase telomerase activity to extend the lifespan.288”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [288]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Kidney pathway differs between Table 1 and the text
MinorTable 1 labels the kidney pathway as MAPK and cites reference 62. The discussion of kidney effects attributed to the same reference instead identifies an AMPK-SIRT1-PGC-1α pathway.
“| Kidney | MAPK | Decreased reactive oxygen species (ROS) and apoptosis | 62 |”
“aerobic exercise participates in alleviating the levels of oxidative stress and apoptosis in impaired kidney tissue following myocardial infraction in part because of activation of the FNDC5/irisin–AMPK–SIRT1–PGC-1α signalling pathway (Ref. 62).”
Ampelopsin row cites the icariin study
MinorTable 2 cites reference 58 for ampelopsin, whereas the text assigns the ampelopsin result to reference 59. Reference 58 is the icariin study.
“| Ampelopsin | AMPK/SIRT1/PGC-α | Rat skeletal muscle | Attenuate atrophy | 58 |”
“Similar effects have been found in rats treated with the flavonoid ampelopsin which attenuates the atrophy of skeletal muscle through activating AMPK/SIRT1/PGC-1α signalling cascade (Ref. 59).”
Vitamin D row cites a resveratrol study
MinorTable 2 cites reference 80 for a human vitamin D intervention, but reference 80 is identified in the paper as a rat study of resveratrol, grape juice and red wine. The vitamin D clinical trial is listed as reference 99.
“| Vitamin D | SIRT1 | human | Decrease glycosylated haemoglobin | 80 |”
“80. de Souza Rocha G (2016) Effects of resveratrol, grape juice or red wine consumption irisin levels and fibronectin type III domain containing protein 5 and uncoupoling protein gene expression modulation in rats.”
Metformin row omits the cited metformin-irisin studies
MinorTable 2 lists references 74 and 75 for metformin, but the text cites references 76 and 77 for the metformin effects on irisin that the row describes.
“| Metformin | SIRT1 | INS-1E cellsObese mice | Improve pancreatic cells survival | 74, 75 |”
“can promote up-regulating irisin expression in mice muscle (Ref. 76) and in INS-1E cells in high-glucose environment through AMPK/SIRT1/PGC-1α signal pathway, improving its function and survival (Ref. 77).”
Icariin row cites the AMPK knockout study
MinorTable 2 cites reference 57 for icariin, but the text attributes the icariin experiment to reference 58. Reference 57 is the skeletal-muscle AMPK knockout study.
“| Icariin | AMPK | C2C12 myocytes, mice | Decrease body weight gain | 57 |”
“Moreover, a study demonstrated that AMPK pathway is involved in the PGC-1α/FNDC5 and irisin expression using a flavonoid, icariin, which enhances dose-dependent phosphorylation of AMPK protein and increased mRNA levels of irisin/FNDC5 in C2C12 myocytes and decreased body weight gain in mice (Ref. 58).”
Cites
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567 · see citing works
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · see citing works
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · see citing works
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008 · see citing works
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624 · see citing works
Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway
Wrann, C. D., White, J. P., Salogiannnis, J., Laznik-Bogoslavski, D., Wu, J., Ma, D., Lin, J. D., Greenberg, M. E., & Spiegelman, B. M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.008 · Cited by 1,440 · see citing works
Autophagy in healthy aging and disease
Aman, Y., Schmauck-Medina, T., Hansen, M., Morimoto, R. I., Simon, A. K., Bjedov, I., Palikaras, K., Simonsen, A., Johansen, T., Tavernarakis, N., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00098-4 · Cited by 1,313 · see citing works
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242 · see citing works
Muscle–Organ Crosstalk: The Emerging Roles of Myokines
Severinsen, M. C. K., & Pedersen, B. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa016 · Cited by 1,226 · cited 1× · see citing works
“18).”
Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0275-4 · Cited by 935 · see citing works
Choi, S. H., Bylykbashi, E., Chatila, Z. K., Lee, S. W., Pulli, B., Clemenson, G. D., Kim, E., Rompala, A., Oram, M. K., Asselin, C., et al. (2018) · Science · doi:10.1126/science.aan8821 · Cited by 802 · see citing works
AMPK signalling in health and disease
Carling, D. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.01.005 · Cited by 797 · see citing works
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754 · see citing works
Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., et al. (2014) · Diabetes · doi:10.2337/db13-1106 · Cited by 733 · cited 1× · see citing works
“22).”
SIRT1 and aging related signaling pathways
Chen, C., Zhou, M., Ge, Y., & Wang, X. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111215 · Cited by 693 · see citing works
Telomeres, lifestyle, cancer, and aging
Shammas, M. A. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834121b1 · Cited by 685 · see citing works
Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors
Kim, H., Wrann, C. D., Jedrychowski, M., Vidoni, S., Kitase, Y., Nagano, K., Zhou, C., Chou, J., Parkman, V.-J. A., Novick, S. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.025 · Cited by 638 · see citing works
FNDC5/irisin is not only a myokine but also an adipokine
Roca-Rivada, A., Castelao, C., Senin, L. L., Landrove, M. O., Baltar, J., Crujeiras, A. B., Seoane, L. M., Casanueva, F. F., & Pardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060563 · Cited by 612 · see citing works
The Browning of White Adipose Tissue: Some Burning Issues
Nedergaard, J., & Cannon, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.005 · Cited by 500 · see citing works
AMPK at the Nexus of Energetics and Aging
Burkewitz, K., Zhang, Y., & Mair, W. B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.002 · Cited by 483 · see citing works
Exercise hormone irisin is a critical regulator of cognitive function
Islam, M. R., Valaris, S., Young, M. F., Haley, E. B., Luo, R., Bond, S. F., Mazuera, S., Kitchen, R. R., Caldarone, B. J., Bettio, L. E. B., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00438-z · Cited by 403 · see citing works
Braunstein, M., Sobel, R. E., Allis, C. D., Turner, B. M., & Broach, J. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4349 · Cited by 367 · see citing works
Huh, J. Y., Mougios, V., Kabasakalis, A., Fatouros, I., Siopi, A., Douroudos, I. I., Filippaios, A., Panagiotou, G., Park, K. H., & Mantzoros, C. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1437 · Cited by 363 · see citing works
Effect of resveratrol and pterostilbene on aging and longevity
Li, Y., Li, S., & Lin, C. (2017) · BioFactors · doi:10.1002/biof.1400 · Cited by 348 · see citing works
Li, D., Li, Y., Yuan, H., Qu, L., & Wang, P. (2016) · Metabolism · doi:10.1016/j.metabol.2016.12.003 · Cited by 308 · see citing works
Qiao, X., Nie, Y., Ma, Y., Chen, Y., Cheng, R., Yin, W., Hu, Y., Xu, W., & Xu, L. (2016) · Scientific Reports · doi:10.1038/srep18732 · Cited by 291 · see citing works
Polyzos, S. A., Anastasilakis, A. D., Efstathiadou, Z. A., Makras, P., Perakakis, N., Kountouras, J., & Mantzoros, C. S. (2018) · Endocrine · doi:10.1007/s12020-017-1476-1 · Cited by 262 · see citing works
Exercise induces autophagy in peripheral tissues and in the brain
He, C., Sumpter, R., & Levine, B. (2012) · Autophagy · doi:10.4161/auto.21327 · Cited by 259 · see citing works
AMPK Activation of Muscle Autophagy Prevents Fasting-Induced Hypoglycemia and Myopathy during Aging
Bujak, A. L., Crane, J. D., Lally, J., Ford, R. J., Kang, S. J., Rebalka, I. A., Green, A. E., Kemp, B. E., Hawke, T. J., Schertzer, J. D., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.016 · Cited by 252 · see citing works
Progress and Challenges in the Biology of FNDC5 and Irisin
Maak, S., Norheim, F., Drevon, C. A., & Erickson, H. P. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab003 · Cited by 247 · see citing works
The Structure of Irisin Reveals a Novel Intersubunit β-Sheet Fibronectin Type III (FNIII) Dimer
Schumacher, M. A., Chinnam, N. B., Ohashi, T., Shah, R., & Erickson, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.516641 · Cited by 240 · see citing works
Exercise Training Promotes SIRT1 Activity in Aged Rats
Ferrara, N., Rinaldi, B., Corbi, G., Conti, V., Stiuso, P., Boccuti, S., Rengo, G., Rossi, F., & Filippelli, A. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0576 · Cited by 238 · see citing works
Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
Zhang, H.-J., Zhang, X.-F., Ma, Z.-M., Pan, L.-L., Chen, Z., Han, H.-W., Han, C.-K., Zhuang, X.-J., Lu, Y., Li, X.-J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.030 · Cited by 234 · see citing works
Aydin, S., Kuloglu, T., Aydin, S., Kalayci, M., Yilmaz, M., Cakmak, T., Albayrak, S., Gungor, S., Colakoglu, N., & Ozercan, İ. H. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.014 · Cited by 233 · see citing works
Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK
Lee, H. J., Lee, J. O., Kim, N., Kim, J. K., Kim, H. I., Lee, Y. W., Kim, S. J., Choi, J., Oh, Y., Kim, J. H., et al. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1353 · Cited by 219 · see citing works
Irisin in response to exercise in humans with and without metabolic syndrome
Huh, J. Y., Siopi, A., Mougios, V., Park, K. H., & Mantzoros, C. S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2416 · Cited by 210 · see citing works
Autophagy in aging and longevity
Wong, S. Q., Kumar, A. V., Mills, J., & Lapierre, L. R. (2019) · Human Genetics · doi:10.1007/s00439-019-02031-7 · Cited by 204 · see citing works
Mazur-Bialy, A. I., Pocheć, E., & Zarawski, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040701 · Cited by 203 · see citing works
Li, X., Jamal, M., Guo, P., Jin, Z. Y., Zheng, F., Song, X., Zhan, J., & Wu, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109363 · Cited by 196 · see citing works
FNDC5/Irisin: Physiology and Pathophysiology
Waseem, R., Shamsi, A., Mohammad, T., Hassan, M. I., Kazim, S. N., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M., Ahmad, F., & Islam, A. (2022) · Molecules · doi:10.3390/molecules27031118 · Cited by 180 · see citing works
New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
Rabiee, F., Lachinani, L., Ghaedi, S., Nasr‐Esfahani, M. H., Megraw, T. L., & Ghaedi, K. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00413-3 · Cited by 178 · see citing works
Aydın, S., Kuloğlu, T., Aydin, S., Eren, M. N., Çelik, A., Yılmaz, M., Kalaycı, M. Z., Şahin, İ., Gungor, O., Gürel, A., et al. (2013) · Peptides · doi:10.1016/j.peptides.2013.11.024 · Cited by 165 · see citing works
Li, R., Wu, S., Yao, W., Wang, X., Chen, H., Xin, J.-J., Li, H., Lan, J., Xue, K., Li, X., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.07.250 · Cited by 163 · see citing works
Castillo-Quan, J. I. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009894 · Cited by 157 · see citing works
Fu, J.-J., Han, Y., Wang, J., Liu, Y., Zheng, S., Zhou, L., Jose, P., & Zeng, C. (2016) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.116.003433 · Cited by 139 · see citing works
Lin, J., Kuo, W., Baskaran, R., Kuo, C., Chen, Y., Chen, W. S., Ho, T., Day, C. H., Mahalakshmi, B., & Huang, C. (2020) · Aging · doi:10.18632/aging.103046 · Cited by 133 · see citing works
Skeletal muscle as a gene regulatory endocrine organ
Karstoft, K., & Pedersen, B. K. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000283 · Cited by 132 · see citing works
Pignataro, P., Dicarlo, M., Zerlotin, R., Zecca, C., Dell’Abate, M. T., Buccoliero, C., Logroscino, G., Colucci, S. C., & Grano, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041605 · Cited by 131 · see citing works
Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
Kam, T.-I., Park, H., Chou, S.-C., Van Vranken, J. G., Mittenbühler, M. J., Kim, H., A, M., Choi, Y. R., Biswas, D., Wang, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204835119 · Cited by 125 · see citing works
Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway
Han, F., Zhang, S., Hou, N., Wang, D., & Sun, X. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00443.2015 · Cited by 123 · see citing works
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
Thellung, S., Corsaro, A., Nizzari, M., Barbieri, F., & Florio, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040901 · Cited by 116 · see citing works
Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway
Liu, J., Song, N., Yi, H., & Chen, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33229-w · Cited by 113 · see citing works
Safarpour, P., Daneshi-Maskooni, M., Vafa, M., Nourbakhsh, M., Janani, L., Maddah, M., Amiri, F.-S., Mohammadi, F., & Sadeghi, H. (2020) · BMC Family Practice · doi:10.1186/s12875-020-1096-3 · Cited by 100 · see citing works
Xin, T., & Lu, C. (2020) · Aging · doi:10.18632/aging.102899 · Cited by 96 · see citing works
Serum Irisin Levels, Precocious Myocardial Infarction, and Healthy Exceptional Longevity
Emanuele, E., Minoretti, P., Pareja-Galeano, H., Sanchis‐Gomar, F., Garatachea, N., & Lucía, A. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.04.025 · Cited by 93 · see citing works
Albrecht, E., Schering, L., Buck, F., Vlach, K., Schober, H., Drevon, C. A., & Maak, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.016 · Cited by 92 · see citing works
Adak, T., Samadi, A., Ünal, A. Z., & Sabuncuoğlu, S. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.12.023 · Cited by 88 · see citing works
Irisin Exerts Neuroprotective Effects on Cultured Neurons by Regulating Astrocytes
Wang, K., Li, H., Wang, H., Wang, J., Song, F., & Sun, Y. S. (2018) · Mediators of Inflammation · doi:10.1155/2018/9070341 · Cited by 86 · see citing works
Wu, F., Li, Z., Cai, M., Xi, Y., Xu, Z., Zhang, Z., Li, H., Zhu, W., & Tian, Z. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.038 · Cited by 83 · see citing works
Kou, X., Li, J., Liu, X., Yang, X., Fan, J., & Chen, N. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.070 · Cited by 81 · see citing works
The “irisin system”: From biological roles to pharmacological and nutraceutical perspectives
Flori, L., Testai, L., & Calderone, V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118954 · Cited by 79 · see citing works
Li, Q.-X., Jia, S.-H., Xu, L., Li, B., & Chen, N. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1006 · Cited by 77 · see citing works
Plasma irisin levels predict telomere length in healthy adults
Rana, K. S., Arif, M., Hill, E. J., Aldred, S., Nagel, D. A., Nevill, A. M., Randeva, H. S., Bailey, C. J., Bellary, S., & Brown, J. E. P. (2014) · AGE · doi:10.1007/s11357-014-9620-9 · Cited by 77 · see citing works
Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease
Lourenco, M. V., Ribeiro, F. C., Sudo, F. K., Drummond, C., Assunção, N., Vanderborght, B., Tovar-Moll, F. F., Mattos, P., Felice, F. G. D., & Ferreira, S. T. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12034 · Cited by 76 · see citing works
Ruan, Q., Huang, Y., Yang, L., Ruan, J., Gu, W., Zhang, X., Zhang, Y., Zhang, W., & Yu, Z. (2019) · Peptides · doi:10.1016/j.peptides.2019.01.004 · Cited by 76 · see citing works
Successive bouts of cycling stimulates genes associated with mitochondrial biogenesis
Dumke, C. L., Davis, J. M., Murphy, E. A., Nieman, D. C., Carmichael, M. D., Quindry, J. C., Triplett, N. T., Utter, A. C., Gross, S. J., Henson, D. A., et al. (2009) · European Journal of Applied Physiology · doi:10.1007/s00421-009-1143-1 · Cited by 72 · see citing works
Irisin reverses insulin resistance in C2C12 cells via the p38-MAPK-PGC-1α pathway
Ye, X., Shen, Y., Ni, C., Ye, J., Xin, Y., Zhang, W., & Ren, Y. (2019) · Peptides · doi:10.1016/j.peptides.2019.170120 · Cited by 72 · see citing works
Biogerontology: from here to where? The Lord Cohen Medal Lecture-2011
Rattan, S. I. S. (2011) · Biogerontology · doi:10.1007/s10522-011-9354-3 · Cited by 72 · see citing works
Irisin Exerts Inhibitory Effect on Adipogenesis Through Regulation of Wnt Signaling
Ma, E. B., Sahar, N.-E., Jeong, M., & Huh, J. Y. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01085 · Cited by 69 · see citing works
Irisin Improves Autophagy of Aged Hepatocytes via Increasing Telomerase Activity in Liver Injury
Bi, J.-B., Yang, L.-F., Wang, T., Zhang, J., Li, T., Ren, Y., Wang, M.-Z., Chen, X., Lv, Y., & Wu, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6946037 · Cited by 66 · see citing works
Zhang, D., Xie, T., & Leung, P. S. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495395 · Cited by 65 · cited 1× · see citing works
“60).”
Effect of resveratrol on expression of genes involved thermogenesis in mice and humans
Andrade, J. M. O., Barcala-Jorge, A. S., Batista-Jorge, G. C., Paraíso, A. F., de Freitas, K. M., Lelis, D. D. F., Guimarães, A. L. S., de Paula, A. M. B., & Santos, S. H. S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108634 · Cited by 64 · see citing works
Irisin ameliorates angiotensin II‐induced cardiomyocyte apoptosis through autophagy
Li, R., Wang, X., Wu, S., Yao, W., Chen, H., Xin, J., Li, H., Lan, J., Xue, K., Li, X., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28382 · Cited by 64 · see citing works
Detection and quantitation of irisin in human cerebrospinal fluid by tandem mass spectrometry
Ruan, Q., Zhang, L.-M., Ruan, J., Zhang, X.-X., Chen, J., Ma, C., & Yu, Z. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.013 · Cited by 62 · see citing works
Long-Term Effect of Exercise on Irisin Blood Levels—Systematic Review and Meta-Analysis
Jandova, T., Buendía‐Romero, Á., Polanská, H., Hola, V., Říhova, M., Větrovský, T., Courel‐Ibáñez, J., & Šteffl, M. (2021) · Healthcare · doi:10.3390/healthcare9111438 · Cited by 61 · see citing works
Bonfante, I. L. P., Chacon‐Mikahil, M. P. T., Brunelli, D. T., Gáspari, A. F., Duft, R. G., Lopes, W. A., Bonganha, V., Libardi, C. A., & Cavaglieri, C. R. (2017) · European Journal of Sport Science · doi:10.1080/17461391.2017.1296025 · Cited by 60 · see citing works
Irisin and Autophagy: First Update
Pesce, M., Ballerini, P., Paolucci, T., Puca, I., Farzaei, M. H., & Patruno, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207587 · Cited by 59 · see citing works
Dinas, P. C., Lahart, I. M., Timmons, J. A., Svensson, P.-A., Koutedakis, Y., Flouris, A. D., & Metsios, G. S. (2017) · F1000Research · doi:10.12688/f1000research.11107.2 · Cited by 51 · see citing works
Icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway
Chen, S., Ding, L., Zeng, N.-X., Liu, H., Zheng, S., Xu, J.-W., & Li, R. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108930 · Cited by 50 · see citing works
Lower irisin levels in coronary artery disease: a meta-analysis
Guo, W., Zhang, B., & Wang, X. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.17.02663-3 · Cited by 49 · see citing works
Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer’s disease
Madhu, L. N., Somayaji, Y., & Shetty, A. K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101637 · Cited by 49 · see citing works
Palacios‐González, B., Vargas‐Castillo, A., Velázquez‐Villegas, L. A., Vásquez‐Reyes, S., López, P., Noriega, L. G., Alemán, G., Tovar‐Palacio, C., Torre-Villalvazo, I., Yang, L.-J., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.012 · Cited by 46 · see citing works
The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis
Yano, N., Zhao, Y., & Zhao, T. C. (2021) · Endocrines · doi:10.3390/endocrines2030025 · Cited by 46 · see citing works
Noda, Y., Kuzuya, A., Tanigawa, K., Araki, M., Kawai, R., Ma, B., Sasakura, Y., Maesako, M., Tashiro, Y., Miyamoto, M., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0401-8 · Cited by 44 · see citing works
Colpitts, B. H., Rioux, B. V., Eadie, A. L., Brunt, K. R., & Sénéchal, M. (2022) · Physiological Reports · doi:10.14814/phy2.15198 · Cited by 44 · see citing works
Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson's disease.
Zarbakhsh, S., Safari, M., Aldaghi, M. R., Sameni, H. R., Ghahari, L., Lagmouj, Y. K., Jaberi, K. R., & Parsaie, H. (2019) · PubMed Central · doi:10.22038/ijbms.2019.33444.7987 · Cited by 41 · see citing works
Zhou, K., Qiao, X., Cai, Y., Li, A., & Shan, D. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001388 · Cited by 41 · see citing works
Aghasi, M., Zahedi, S. G., Koohdani, F., Siassi, F., Nasli‐Esfahani, E., Keshavarz, A., Qorbani, M., Khoshamal, H., Salari-Moghaddam, A., & Sotoudeh, G. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2068-6 · Cited by 40 · see citing works
ERK1/2 is a key regulator of Fndc5 and PGC1α expression during neural differentiation of mESCs
Farahabadi, S. S. H., Ghaedi, K., Zadegan, F. G., Karbalaie, K., Rabiee, F., Nematollahi, M., Baharvand, H., & Nasr‐Esfahani, M. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.069 · Cited by 39 · see citing works
Camerino, G. M., Fonzino, A., Conte, E., De Bellis, M., Mele, A., Liantonio, A., Tricarico, D., Tarantino, N., Dobrowolny, G., Musarò, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39676-3 · Cited by 38 · see citing works
Lv, J., Pan, Y., Li, X., Cheng, D., Ju, H., Tian, J., Shi, H., & Zhang, Y. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1547261 · Cited by 36 · see citing works
PGC-1 mediates the regulation of metformin in muscle irisin expression and function.
Yang, Z., Xu, C., Chen, Y., & Zhao, Q. (2015) · Europe PMC (PubMed Central) · Cited by 32 · see citing works
Lunetta, C., Lizio, A., Tremolizzo, L., Ruscica, M., Macchi, C., Riva, N., Weydt, P., Corradi, E., Magni, P., & Sansone, V. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9093-3 · Cited by 29 · see citing works
Yue, R., Lv, M., Lan, M., Zheng, Z., Tan, X., Zhao, X., Zhang, Y., Pu, J., Xu, L., & Hu, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-11343-0 · Cited by 29 · see citing works
Irisin injection mimics exercise effects on the brain proteome
Dehghan, F., Zamani, S., Barreiro, C., & Jami, M. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15493 · Cited by 28 · see citing works
Mechanisms of Ageing and Development
(1979) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(79)90049-6 · Cited by 28 · see citing works
Sanchis‐Gomar, F., Garatachea, N., He, Z.-H., Pareja-Galeano, H., Fuku, N., Tian, Y., Arai, Y., Abe, Y., Murakami, H., Miyachi, M., et al. (2014) · AGE · doi:10.1007/s11357-014-9733-1 · Cited by 22 · see citing works
Loss of association between plasma irisin levels and cognition in Alzheimer’s disease
Kim, K. Y., Kwak, S., Ha, J., Oh, D. J., Kim, M., Cho, S. Y., Kim, H., Lee, J., & Kim, E. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105624 · Cited by 22 · see citing works
Skeletal muscle AMPK is essential for the maintenance of FNDC5 expression
Lally, J., Ford, R. J., Johar, J., Crane, J. D., Kemp, B. E., & Steinberg, G. R. (2015) · Physiological Reports · doi:10.14814/phy2.12343 · Cited by 21 · see citing works
The effect of preventive exercise on the neuroprotection in 6-hydroxydopamine-lesioned rat brain
Rezaee, Z., Marandi, S. M., Alaei, H., & Esfarjani, F. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0545 · Cited by 20 · see citing works
Oliveira, F. R., Mamede, M., Bizzi, M., Rocha, A. L., Ferreira, C. N., Gomes, K. B., Cândido, A. L., & Reis, F. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1157-0615 · Cited by 18 · see citing works
Impact of acute circuit training on irisin in younger and older overweight adults
Rioux, B. V., Brunt, K. R., Eadie, A. L., B̀ouchard, D. R., Fox, J., & Sénéchal, M. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-1087 · Cited by 9 · see citing works
Rocha, G. D. S., Ferreira, R. D. S., Pimenta, N. D. M. A., da Fonseca, L. M., Mafra, D., de Azeredo, V. B., da Fonseca, A. D. S., & Barroso, S. G. (2016) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2016.02.001 · Cited by 5 · see citing works
Mohammadi, A., & Roozbayani, M. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22034/jeoct.2022.331972.1030 · Cited by 1 · see citing works
Flagged first, then by citations
2 of the 106 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Mattson, 2018, Cell Metabolism, 27, 1176
Cited by
Sorted by citations
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165 · see citing works
Li, N., Wang, B., Wang, Y., Tian, X., Lin, J., Sun, X., Sun, Y., Zhang, X., Xu, H., Li, M., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04801-z · Cited by 19 · see citing works
Irisin in degenerative musculoskeletal diseases: Functions in system and potential in therapy
Wang, Y.-T., Zheng, S., Jiang, S., Luo, Y., Wu, Y., Naranmandakh, S., Li, Y., Liu, S.-G., & Xiao, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107480 · Cited by 21 · see citing works
Irisin alleviates hepatic steatosis by activating the autophagic SIRT3 pathway
Zhao, Y., Li, J., Ma, A., Wang, Z., Ni, Y., Wu, D., Zhou, Y., Zhang, N., Zhang, L., Chang, Y., et al. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003427 · Cited by 15 · see citing works
Bellettini‐Santos, T., Batista-Silva, H., Pereira, C. M., Castro, F. C. D. A. Q., Barcelos, R. M., Chiepe, K. C. M. B., Rossoni, J. V., Ambrósio, R. P., da Silva, B. S., Chiarelli-Neto, O., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512440 · Cited by 15 · see citing works
Chen, J., Li, G., He, X., Chen, Z., Chen, Z., Liu, D., Guo, S., Huang, T., Lan, P., Lan, P., et al. (2023) · Gastroenterology report · doi:10.1093/gastro/goae045 · Cited by 16 · see citing works
Ketogenic diet with aerobic exercise can induce fat browning: potential roles of β-hydroxybutyrate
Kim, S., Park, D., Moon, S., Gu, B., Mantik, K. E. K., Kwak, H., Ryu, J.-K., & Kang, J.-H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1443483 · Cited by 14 · see citing works
Study on the comorbid mechanisms of sarcopenia and late-life depression
Wu, J., Tang, J., Huang, D., Wang, Y., Zhou, E., Ru, Q., Xu, G., Chen, L., & Wu, Y. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115538 · Cited by 12 · see citing works
Hua, X., Hou, M., Deng, L., Lv, N., Xu, Y. X., Zhu, X., Yang, H., Shi, Q., Liu, H., & He, F. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad096 · Cited by 12 · see citing works
Nozu, T., Miyagishi, S., Ishioh, M., Takakusaki, K., & Okumura, T. (2025) · Peptides · doi:10.1016/j.peptides.2025.171394 · Cited by 9 · see citing works
Xie, J., Li, B., He, C., Yang, S., Yang, S., Sun, P., Zhu, G., & Wang, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119811 · Cited by 9 · see citing works
Irisin: A Potentially Fresh Insight into the Molecular Mechanisms Underlying Vascular Aging
Wang, Y., Wang, M., & Wang, Y. (2023) · Aging and Disease · doi:10.14336/ad.2023.1112 · Cited by 10 · see citing works
Role of irisin in metabolic and cardiovascular disorders and its therapeutic potential
Khalil, R. G., Atia, T. A., Yousef, A. I., Sakr, H. I., & Ahmed, O. M. (2025) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-025-00643-9 · Cited by 8 · see citing works
Targeting SIRT1 synergistically improves the antitumor effect of JQ-1 in hepatocellular carcinoma
Jiang, Y., Miao, X., Wu, Z., Xie, W., Wang, L., Liu, H., & Gong, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22093 · Cited by 8 · see citing works
Zhang, J., Tu, R., Guan, F., Feng, J., Jia, J., Zhou, J. L., Wang, X., & Liu, L. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18259 · Cited by 7 · see citing works
Zhang, Z., Zhang, Y., Zou, X., Li, J., Chi, Y., Bai, H., Wei, B., Yun, H., Zhang, Q., Cao, W., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1560608 · Cited by 7 · see citing works
Protective role of irisin on bone in osteoporosis: a systematic review of rodent studies
Li, J., Fu, X., Shi, H., Jing, J., Zheng, Q., & Xu, Z. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07470-9 · Cited by 6 · see citing works
PRASAD, V. V., Samson, J. S., & Parvathi, V. D. (2024) · Biocell · doi:10.32604/biocell.2024.048776 · Cited by 6 · see citing works
Understanding the Role of Irisin in Longevity and Aging: A Narrative Review
Plácido, A. I., Azevedo, D., Herdeiro, M. T., Morgado, M., & Roque, F. (2025) · Epidemiologia · doi:10.3390/epidemiologia6010001 · Cited by 5 · see citing works
Jiang, H., Inoue, S., Hatakeyama, J., Liu, P., Zhao, T., Zhang, Y., Liu, B., He, C., & Moriyama, H. (2025) · Biogerontology · doi:10.1007/s10522-025-10234-x · Cited by 4 · see citing works
Han, Z., Li, J., Bei, Y., Gao, F., & Chen, Q. (2025) · European journal of medical research · doi:10.1186/s40001-025-02882-z · Cited by 4 · see citing works
PPAR-γ Signaling and Common Protective Pathways against Obesity and Alzheimer's Disease
SHARMA, A. K., Devi, S., Mannan, A., Kumar, M., & Singh, T. G. (2024) · Current Signal Transduction Therapy · doi:10.2174/0115743624267214241016103515 · Cited by 4 · see citing works
High-intensity training and irisin response: A possible molecular cross-talk for irisin response
Li, P., Tong, L., & Bi, X. (2025) · Current Research in Physiology · doi:10.1016/j.crphys.2025.100163 · Cited by 4 · see citing works
Fan, K., Li, X., & Wang, Z. (2025) · The FASEB Journal · doi:10.1096/fj.202501901r · Cited by 2 · see citing works
Therapeutic Potential of Irisin in Neurodegenerative Diseases
Muzaffar, S., Tyagi, A., & Pugazhenthi, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311348 · Cited by 5 · see citing works
Targeting exercise triggered irisin for therapeutic intervention of autism-associated social anxiety
Tatode, A., Gupta, T., Qutub, M., Umekar, M. J., Taksande, B. G., & Premchandani, T. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.11.027 · Cited by 2 · see citing works
The regeneration model of aging and its practical implications
Dassoff, E. (2026) · Discover Medicine · doi:10.1007/s44337-025-00558-5 · Cited by 2 · see citing works
Qin, S., Ma, Y., Ren, W., Xi, Y., Li, H., Bo, W., & Tian, Z. (2026) · The FASEB Journal · doi:10.1096/fj.202500863rrrr · Cited by 2 · see citing works
Voros, C., Chatzinikolaou, F. G., Papadimas, G. K., Papapanagiotou, I., Karpouzos, A., Koulakmanidis, A.-M., Athanasiou, D., Bananis, K., Athanasiou, A. I., Athanasiou, A. V., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083344 · Cited by 3 · see citing works
Yang, Y., Pullisaar, H., Reseland, J. E., & Ma, J. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02623-z · Cited by 1 · see citing works
Sex specific effects of irisin on the skeleton
Shimonty, A., & Bonewald, L. F. (2026) · Bone Research · doi:10.1038/s41413-026-00542-4 · Cited by 1 · see citing works
Main Dietary Patterns for Healthy Aging and Well-Being
Vinci, G., Davì, F., Pellegrino, T., Fusco, R., Cordaro, M., & Paola, R. D. (2025) · Nutrients · doi:10.3390/nu17122009
Physical exercise and irisin: managing obesity and related comorbidities
Negroiu, C. E., Tudorașcu, I., Dănoiu, S., Pădureanu, V., Godeanu, S., Dănoiu, R., Ungureanu, A., Beznă, M. C., & Moise, C. G. (2025) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.66.2.05 · Cited by 1 · see citing works
You, Y., Guo, J., & Yao, W. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-10014-w
Jiang, X., Yang, Y., Zhang, H., Dai, H., Huang, Y., & Yu, X. (2026) · Pharmacognosy Magazine · doi:10.1177/09731296261427823
Wang, S., Gao, Y., Wang, Y., Wang, J., & Liu, Y. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1865475
Zhai, T., Wang, H., An, Y., Deng, M., Zhang, K., Du, Y., Yang, C., Yu, L., & Guo, F. (2026) · The FASEB Journal · doi:10.1096/fj.202600011rr
Wajdi, S. S., Mohyadini, M., Abdlwhab, H. M., Jasim, W. E., & Bathaie, S. Z. (2026) · Intern J Endocrinol Metab · doi:10.5812/ijem-171383
- Authors
- Sánchez, B., Muñoz-Pinto, M. F., & Cano, M.
- Affiliations
- Universidad de Sevilla (ES)
- Corresponding author
- Cano, Mercedes
- Venue
- Expert Reviews in Molecular Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2022-12-12
- Volume
- 25
- Pages
- e4-e4
- ISSN
- 1462-3994 (ISSN-L)
- PMC
- PMC9884770
- OpenAlex
- W4311204811
- Semantic Scholar
- 011f2711433a8eab1f7d36cde596aa2f86482e99
- Cited by
- 38
- References
- 106
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 5 · 2023: 5
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Expert Reviews in Molecular Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Keywords
- irisin, aging, longevity, SIRT1, AMPK, autophagy, telomerase, myokines, physical activity, age-related diseases, therapeutic target
- MeSH terms
- Autophagy, Fibronectins, Humans, Longevity, Telomerase, AMP-Activated Protein Kinases, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review